
A judge is poised to rule in a case that seeks to a revoke the approval of the most common, safe and effective abortion pill regimen, with the potential for consequences to be felt in every state.
Nationally, more than half of reported abortions rely on medication, which is approved for use through the 10th week of pregnancy. Abortion pills are preferred among many patients and providers for their convenience, privacy and cost. Around 40 percent of the country’s clinics, including more than 80 telehealth providers, offer medication abortions only….
More than half of all abortions — and 64% of abortions before 10 weeks of pregnancy — relied on abortion pills in 2020, according to the Centers for Disease Control and Prevention. And in states like Colorado, Iowa, Maine, Nebraska, Vermont and Wyoming, the share of abortions done with medication was 70% or higher.
A decision in favor of removing approval for the regimen would be unprecedented — most likely the first time that a court would order the F.D.A. to revoke a drug against the agency’s will. The F.D.A. would immediately appeal such a ruling, yet if allowed to stand, the decision could have significant ramifications in states where abortion is legal, not just in those trying to restrict it….
https://www.nytimes.com/interactive/2023/03/02/us/abortion-pill-lawsuit-mifepristone.html